ascopubs.org

Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm–Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
ascopubs.org

Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...
Medscape

Long-term Follow up Results of Intraductal Papillary Mucinous Tumors of Pancreas

Of the 67 cases, 27 cases (40.3%) were classified as the main duct type IPMT, 35 cases (52.2%) as the branch duct type IPMT, and five cases (7.5%) as the mixed duct type IPMT. There were 12 adenomas ...
Los Angeles Times

The Pancreatic Cyst Dilemma: Why ‘Watchful Waiting’ Is So Hard

Pancreatic cysts are increasingly found incidentally due to better imaging technology. The primary goal is to distinguish pre-cancerous mucinous cysts (like IPMNs) from benign non-mucinous cysts.
Business Wire

Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...